Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04NNJ
|
||||
Former ID |
DNC011938
|
||||
Drug Name |
ZANOTERONE
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Prostate hyperplasia [ICD10:N40] | Phase 3 | [545244] | ||
Structure |
Download2D MOL |
||||
Formula |
C23H32N2O3S
|
||||
Canonical SMILES |
CC12CCC3C(C1CCC2(C#C)O)CCC4C3(CC5=CN(N=C5C4)S(=O)(=O)C)<br />C
|
||||
InChI |
1S/C23H32N2O3S/c1-5-23(26)11-9-19-17-7-6-16-12-20-15(14-25(24-20)29(4,27)28)13-21(16,2)18(17)8-10-22(19,23)3/h1,14,16-19,26H,6-13H2,2-4H3/t16-,17+,18-,19-,21-,22-,23-/m0/s1
|
||||
InChIKey |
MHDDZDPNIDVLNK-ZGIWMXSJSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Androgen receptor | Target Info | Inhibitor | [527548] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Coregulation of Androgen receptor activity | |||||
Regulation of Androgen receptor activity | |||||
Nongenotropic Androgen signaling | |||||
Regulation of nuclear beta catenin signaling and target gene transcription | |||||
FOXA1 transcription factor network | |||||
Notch-mediated HES/HEY network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.